MCP-1/CCR2 signaling is involved in numerous neuroinflammatory diseases, such as multiple sclerosis, stroke, and Alzheimer’s disease [14–19]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.